AI Therapeutics
AI Therapeutics uses data mining and deep learning to develop treatments for rare orphan diseases. The company identifies targets and optimizes drug candidates with AI-driven analysis. Current clinical-stage drug candidates target Group 1 and Group 3 Pulmonary Hypertension and bronchiolitis obliterans syndrome after lung transplant. Category: biotech/biopharma focused on orphan indications. The pipeline aims to partner with pharma for advancement and broader patient reach.
AI Therapeutics
AI Therapeutics uses data mining and deep learning to develop treatments for rare orphan diseases. The company identifies targets and optimizes drug candidates with AI-driven analysis. Current clinical-stage drug candidates target Group 1 and Group 3 Pulmonary Hypertension and bronchiolitis obliterans syndrome after lung transplant. Category: biotech/biopharma focused on orphan indications. The pipeline aims to partner with pharma for advancement and broader patient reach.